Industry
Pharmaceuticals
Topic
IPOs
People
Find news about people
Organizations
Find news about organizations
Alumni
Find news on alumni of any org
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
IPOs in Pharmaceuticals
... NEW YORK, Sept. 20, 2017 (GLOBE NEWSWIRE) -- Zai Lab Limited ("Zai Lab") announces the pricing of its U.S. initial public offering of ...
... YAVNE, Israel, Sept. 18, 2017 (GLOBE NEWSWIRE) -- MediWound Ltd. (NASDAQ:MDWD), a fully integrated biopharmaceutical company specializing in innovative therapies to address ...
... and KING OF PRUSSIA, Pa., Sept. 18, 2017 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ:NBRV) today announced that it has commenced an underwritten public offering ...
... Array BioPharma Inc. (Nasdaq: ARRY) today announced that it has commenced an underwritten public offering ...
... list on the Nasdaq as "FAT." EXITS [ts_bullet_primary] Merck agreed to acquire Rigontec , a Germany-based company that focuses on RIG-I targeting RNA therapeutics. According ...
... lull in activity in the city than the size of the IPO. Verona Pharma reported phase 2a data showing that adding RPL554 to Boehringer Ingelheim’s ...
... WESTLAKE VILLAGE, Calif., Sept. 07, 2017 (GLOBE NEWSWIRE) -- Sienna Biopharmaceuticals, Inc. (NASDAQ:SNNA) today reported the Company's financial results for the second quarter ...
... Rhythm Pharmaceuticals, a 2016 Fierce 15 winner, is looking to get off a ...
... Destiny Pharma has listed on London’s AIM exchange. The IPO gives Destiny £15.3 ...
... LLP is investigating potential claims against Forterra, Inc., Foundation Medicine, Inc., Teva Pharmaceutical Industries Limited, and Dr. Reddys Laboratories Limited as detailed below: Forterra, Inc. ...
... Krystal Biotech has filed to raise about $35 million in a Nasdaq IPO. ...
... transferring the technology from Paratek and gearing up for talks with regulators. ZL-2301 is further back still and represents a more speculative punt for Zai ...
... of $7.6 Million EAGLE, Idaho, Aug. 14, 2017 (GLOBE NEWSWIRE) -- Â PetIQ, Inc. ("PetIQ" or the "Company") (NASDAQ:PETQ), a leading pet medication and wellness ...
... Initial clinical data showing anti-tumor activity with ALRN-6924 presented at ASCO 2017Â -Presentation selected for Best of ASCO Meetings Ongoing ...
... SAN DIEGO, Aug. 09, 2017 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (NASDAQ:KURA), a clinical-stage biopharmaceutical company focused on the development of precision ...
... CITIUS PHARMACEUTICALS, INC.(NASDAQ: CTXR), a specialty pharmaceutical company focused on adjunctive cancer care and ...
... Clementia Pharmaceuticals Inc. (NASDAQ: CMTA) (the "Company" or "Clementia"), a clinical stage biopharmaceutical company, today ...
... EAGLE, Idaho, July 20, 2017 (GLOBE NEWSWIRE) -- PetIQ, Inc. ("PetIQ" or the "Company") announced today the pricing of its initial public ...
... Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company developing innovative medicines targeting microRNAs, today announced ...
... BERKELEY HEIGHTS, N.J., July 19, 2017 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) (Cyclacel or the Company), a clinical-stage biopharmaceutical company using cell ...
... IPO. Erytech Pharma struck another deal to advance its metabolic disease pipeline. Enterome spun off the diagnostic side of its business into a joint venture ...
... Akcea Therapeutics, Inc. today announced the pricing of its initial public offering of 15,625,000 ...
... Zealand Pharma has become the latest European biotech to file for a Nasdaq ...
... Clementia Pharmaceuticals has filed to raise $115 million in an IPO. The Canadian ...
... Montreal drug developer Clementia Pharmaceuticals Inc. has filed to go public in the United States to fund ...
Want to see the full history of news or view news on a particular date? Upgrade to RelSci Professional now!
Start My Free Trial ➤